TIMELESS promotes the proliferation and migration of lung adenocarcinoma cells by activating EGFR through AMPK and SPHK1 regulation

癌症研究 蛋白激酶B 生物 表皮生长因子受体 安普克 PI3K/AKT/mTOR通路 细胞生物学 蛋白质组学 基因敲除 腺癌 蛋白激酶A 激酶 磷酸化 信号转导 癌症 细胞培养 生物化学 遗传学 基因
作者
Houqing Yin,Zequn Wang,Dan Wang,Muhadaisi Nuer,Mengyuan Han,Peng Ren,Shuaipeng Ma,Chutong Lin,Jingjing Chen,Haocheng Xian,Dongmei Ai,Xuejun Li,Shaohua Ma,Zhiqiang Liu,Yan Pan
出处
期刊:European Journal of Pharmacology [Elsevier]
卷期号:955: 175883-175883 被引量:2
标识
DOI:10.1016/j.ejphar.2023.175883
摘要

Lung adenocarcinoma (LUAD) has high morbidity and is prone to recurrence. TIMELESS (TIM), which regulates circadian rhythms in Drosophila, is highly expressed in various tumors. Its role in LUAD has gained attention, but the detailed function and mechanism have not been clarified completely at present.Tumor samples from patients with LUAD patient data from public databases were used to confirm the relationship of TIM expression with lung cancer. LUAD cell lines were used and siRNA of TIM was adopted to knock down TIM expression in LUAD cells, and further cell proliferation, migration and colony formation were analyzed. By using Western blot and qPCR, we detected the influence of TIM on epidermal growth factor receptor (EGFR), sphingosine kinase 1 (SPHK1) and AMP-activated protein kinase (AMPK). With proteomics analysis, we comprehensively inspected the different changed proteins influenced by TIM and did global bioinformatic analysis.We found that TIM expression was elevated in LUAD and that this high expression was positively correlated with more advanced tumor pathological stages and shorter overall and disease-free survival. TIM knockdown inhibited EGFR activation and also AKT/mTOR phosphorylation. We also clarified that TIM regulated the activation of SPHK1 in LUAD cells. And with SPHK1 siRNA to knock down the expression level of SPHK1, we found that EGFR activation were inhibited greatly too. Quantitative proteomics techniques combined with bioinformatics analysis clarified the global molecular mechanisms regulated by TIM in LUAD. The results of proteomics suggested that mitochondrial translation elongation and termination were altered, which were closely related to the process of mitochondrial oxidative phosphorylation. We further confirmed that TIM knockdown reduced ATP content and promoted AMPK activation in LUAD cells.Our study revealed that siTIM could inhibit EGFR activation through activating AMPK and inhibiting SPHK1 expression, as well as influencing mitochondrial function and altering the ATP level; TIM's high expression in LUAD is an important factor and a potential key target in LUAD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
qmx完成签到,获得积分10
1秒前
4秒前
哈哈哈哈哈完成签到,获得积分10
6秒前
7秒前
8秒前
脑洞疼应助科研通管家采纳,获得10
9秒前
深情安青应助科研通管家采纳,获得10
9秒前
Owen应助科研通管家采纳,获得10
9秒前
NexusExplorer应助科研通管家采纳,获得10
9秒前
小马甲应助科研通管家采纳,获得10
9秒前
桐桐应助科研通管家采纳,获得10
9秒前
ding应助科研通管家采纳,获得10
9秒前
beijixing1990应助科研通管家采纳,获得10
9秒前
科研通AI2S应助科研通管家采纳,获得10
9秒前
10秒前
小许完成签到 ,获得积分10
12秒前
12秒前
Dr.c发布了新的文献求助10
12秒前
李健的粉丝团团长应助ghy采纳,获得20
14秒前
十二发布了新的文献求助10
16秒前
hfhkjh完成签到,获得积分20
16秒前
别潜然发布了新的文献求助10
17秒前
斯文败类应助兜兜采纳,获得10
20秒前
希望天下0贩的0应助WYL采纳,获得10
22秒前
22秒前
26秒前
28秒前
别云间发布了新的文献求助10
28秒前
兜兜发布了新的文献求助10
33秒前
共享精神应助Li采纳,获得10
36秒前
37秒前
qq78910给qq78910的求助进行了留言
38秒前
lh发布了新的文献求助10
40秒前
青天鸟1989完成签到,获得积分10
40秒前
austin发布了新的文献求助10
41秒前
41秒前
可爱的函函应助xiaolanou采纳,获得10
42秒前
张文文发布了新的文献求助10
47秒前
Dr.c发布了新的文献求助10
47秒前
48秒前
高分求助中
The Illustrated History of Gymnastics 800
The Bourse of Babylon : market quotations in the astronomical diaries of Babylonia 680
Division and square root. Digit-recurrence algorithms and implementations 500
機能營養學前瞻(3 Ed.) 300
Problems of transcultural communication 300
Zwischen Selbstbestimmung und Selbstbehauptung 300
Johann Gottlieb Fichte: Die späten wissenschaftlichen Vorlesungen / IV,1: ›Transzendentale Logik I (1812)‹ 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2504732
求助须知:如何正确求助?哪些是违规求助? 2157782
关于积分的说明 5522705
捐赠科研通 1878190
什么是DOI,文献DOI怎么找? 934137
版权声明 563932
科研通“疑难数据库(出版商)”最低求助积分说明 498937